# Combino Pharm (Malta) Ltd – FDA Inspection, Mar 10, 2022

Source: https://www.keypedia.com/records/fda_inspections/combino-pharm-malta-ltd/a0c0e56c-2e3d-4abf-8bc7-47f4da5127bd
Source feed: FDA_Inspections

> FDA inspection 1268103 of Combino Pharm (Malta) Ltd, March 10, 2022. Classification: Voluntary Action Indicated (VAI). 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1268103
- Company Name: Combino Pharm (Malta) Ltd
- Inspection Date: 2022-03-10
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1120331 - 2019-07-17
- [FDA Inspection 1006240 - 2017-03-03](https://www.keypedia.com/records/fda_inspections/combino-pharm-malta-ltd/02cc948c-0e6c-4993-bdb7-f9fdb015ab03)

Company: https://www.keypedia.com/companies/combino-pharm-malta-ltd/69279252-77b5-41d8-8c00-f09982f117f8

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c